Increased ADORA2A could inhibit astrocyte activation in the model of CCH-induced white matter lesions and suppress the inflammatory response, thereby alleviating the white matter injury caused by chronic hypoxia. Here, ADORA2A is linked to columnar cell hyperplasia of the breast.